Katelijn M. Blok
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Symptoms of depression and anxiety are early predictors of multi-domain disability progression in progressive MS.
Journal: Journal of neurology
Published: November 22, 2025
Multifaceted Biomarkers Suggest a Similar Profile of CNS Pathology in Relapsing and Progressive MS.
Journal: European journal of neurology
Published: October 03, 2024
Reasons Patients With Primary Progressive Multiple Sclerosis Contact Their Specialist Nurses.
Journal: International journal of MS care
Published: January 12, 2024
Ocrelizumab associates with reduced cerebrospinal fluid B and CD20dim CD4+ T cells in primary progressive multiple sclerosis.
Journal: Brain communications
Published: September 25, 2023
Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis.
Journal: Frontiers in neurology
Published: August 14, 2023
Real-world challenges in the diagnosis of primary progressive multiple sclerosis.
Journal: European journal of neurology
Published: August 16, 2022
Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib.
Journal: JCI insight
Published: April 08, 2022
Distinct Effector Programs of Brain-Homing CD8+ T Cells in Multiple Sclerosis.
Journal: Cells
Published: March 17, 2022
Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 15, 2020
Brain-homing CD4+ T cells display glucocorticoid-resistant features in MS.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: May 07, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026